The HUMANUS Syndicate allows accredited investors to co-invest alongside Jason Carvalho in select, high-conviction SpaceTech, national security, and dual-use frontier technology companies.

Each investment is executed through a single-deal SPV on AngelList, providing LPs with deal-by-deal discretion and early access to opportunities typically available only to institutional or strategic capital.

The syndicate is led by Jason Carvalho, founder of Carvalho Capital and managing partner of HUMANUS.VC. Over the past six years, through his family office, Jason has backed pre-seed and seed-stage SpaceTech and frontier technology companies operating across NASA, the U.S. Space Force, and allied defense ecosystems in North America.

Jason is also a long-standing mentor in the Creative Destruction Lab (CDL) Space Stream, working with deep-tech founders in partnership with leading universities, government stakeholders, and global venture networks. This experience informs HUMANUS’s investment approach, combining early technical access, ecosystem-level insight, and conviction-led capital deployment.

WHAT LPs GET ACCESS TO:

• Early, defense-aligned SpaceTech and dual-use frontier companies

• High-conviction opportunities sourced prior to institutional scaling

• Curated SPVs led directly by the syndicate lead

• Dealflow originating from direct founder relationships and trusted sector networks

INVESTMENT FOCUS:

• Orbital & Space Infrastructure

• In-Space Logistics & Mobility

• National Security & Dual-Use Systems

• Advanced Aerospace Platforms

• AI, Autonomy & Software for Space Operations

All investments are exclusively in companies headquartered in Five Eyes nations (United States, Canada, United Kingdom, Australia, and New Zealand), ensuring alignment with defense policy, export controls, and national security frameworks.

RISK DISCLOSURE:

Investments in early-stage private companies are speculative and involve substantial risk, including the potential loss of all invested capital. These investments are illiquid, long-term in nature (often 10+ years), and suitable only for accredited investors.

Invest with HUMANUS Syndicate

$253.3k

1

37

Team